Accutest Drug Dip Test 5 Panel (NIDA 5) – 25/Box (AMP / COC / PCP / OPI / THC)
$100.00
CLIA Moderate Complexity
Professional Use
25 tests per box•$4.00 per test
The Accutest 5 Panel Drug Dip Test is a one-step urine screening card for the simultaneous, qualitative detection of amphetamine, cocaine metabolite, opiates, phencyclidine and marijuana metabolite. Read results at five minutes.
- Screens AMP, COC, OPI, PCP and THC
- Simple dip-card format with no instrument required
- Built-in procedural control
- No reagents required
- 25 individually packaged tests per box
| 1-5 | 6-10 | 11+ |
| $100.00 | $92.00 | $87.00 |
Accutest 5 Panel Drug Dip Test Overview
The Accutest 5 Panel Drug Dip Test, reference DS61AC425, is a lateral-flow chromatographic immunoassay for the simultaneous, qualitative detection of five drugs and drug metabolites in human urine. This traditional NIDA 5 configuration screens for amphetamine, cocaine metabolite, opiates, phencyclidine and marijuana metabolite.
5-Panel Screening
Results at 5 Minutes
25 Tests per Box
Features and Benefits
Screens AMP, COC, OPI, PCP and THC simultaneously.
Drug-screen results should be read at five minutes.
Immerse the exposed test strips directly into a collected urine specimen.
Results are interpreted visually without a separate reader or analyzer.
The control line indicates adequate specimen volume, membrane wicking and proper procedure.
Performance agreement varies by analyte and comparison method; refer to the package insert for complete study data.
Product Details
DS61AC425
DTK-109058
| Brand | Accutest |
| Manufacturer | Jant Pharmacal Corporation |
| Test format | Five-panel urine drug-screen dip card |
| Specimen | Human urine |
| Test method | Lateral-flow chromatographic immunoassay |
| Result time | Read at 5 minutes |
| Regulatory status | FDA 510(k) cleared; CLIA moderate complexity; professional use |
| Adulteration testing | Not included in this configuration |
| Package size | 25 tests per box |
| Storage | Store in the sealed pouch at 36–86°F (2–30°C); do not freeze |
Detectable Drugs and Cutoffs
| Detected analyte | Abbreviation | Calibrator | Cutoff |
|---|---|---|---|
| Amphetamine | AMP | d-Amphetamine | 1,000 ng/mL |
| Cocaine metabolite | COC | Benzoylecgonine | 300 ng/mL |
| Opiates | OPI | Morphine | 2,000 ng/mL |
| Phencyclidine | PCP | Phencyclidine | 25 ng/mL |
| Marijuana metabolite | THC | 11-nor-Δ9-THC-9-COOH | 50 ng/mL |
Cutoffs indicate the concentrations used by the screening assay. They do not represent the amount of a drug consumed, the time of consumption or the degree of impairment.
How to Perform the Test
- Allow the test card, urine specimen and controls, if used, to reach room temperature between 59–86°F (15–30°C).
- Remove the test card from its sealed pouch and use it promptly.
- Remove the cap from the end of the test card.
- With the arrows pointing toward the urine specimen, immerse the exposed strips vertically in the urine for at least 10–15 seconds.
- Immerse the strips to at least the level of the wavy lines, but do not allow the urine level to pass above the arrows.
- Replace the cap, place the card on a flat, nonabsorbent surface and start the timer.
- Read the drug-screen results at five minutes.
Important: Review the complete package insert before performing the test. A clean, dry urine collection container and timer are required but are not supplied with the test cards.
Understanding the Results
| Negative | Two colored lines appear for the applicable panel: one in the control region and one in the test region. Any visible test line, even a faint line, should be interpreted as negative. |
| Presumptive positive | A control line appears, but no test line appears for the applicable drug panel. The analyte may be present at or above the stated cutoff. |
| Invalid | No control line appears. Review the procedure and repeat the test using a new test card. |
Preliminary screening only: This test provides a qualitative, preliminary analytical result. Presumptive positive results should be confirmed using a more specific analytical method. Gas chromatography/mass spectrometry is identified in the package insert as the preferred confirmatory method. Clinical consideration and professional judgment should be applied to all drug-screening results.
Instructions and Product Documents
Frequently Asked Questions
Which drugs does the Accutest DS61AC425 screen for?
It screens human urine for amphetamine, cocaine metabolite, opiates, phencyclidine and marijuana metabolite.
Is DS61AC425 CLIA-waived?
No. The exact DS61AC425 dip-card configuration is identified as CLIA moderately complex. It should not be confused with separate Accutest cassette or cup configurations that may be CLIA-waived.
Is this an over-the-counter drug test?
This page should not market DS61AC425 as an OTC test. The package insert identifies the test for healthcare professionals, including professionals at point-of-care sites.
How quickly should the results be read?
The drug-screen results should be read at five minutes, following the instructions supplied with the product.
Does the box include a urine collection cup?
No. A clean, dry specimen collection container is required but is not provided with the test cards.
Does a faint test line mean the result is negative?
Yes. Any visible colored line in the test region should be interpreted as negative, even when the line is faint. A control line must also appear for the result to be valid.
Does a presumptive positive result require confirmation?
Yes. This product provides preliminary qualitative screening results. A more specific analytical method should be used to obtain a confirmed result.
How should the test cards be stored?
Store the cards in their sealed pouches at 36–86°F (2–30°C). Do not freeze them, and do not use a test after the expiration date printed on its sealed pouch.
Additional information
| Weight | 1 lbs |
|---|---|
| Dimensions | 7 × 5 × 3 in |
